solian 200 mg tabletes
sanofi winthrop industrie, france - amisulprīds - tablete - 200 mg
sarclisa
sanofi winthrop industrie - isatuximab - multiple mieloma - antineoplastiski līdzekļi - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imūnsupresanti - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
stilnox 10 mg apvalkotās tabletes
sanofi-aventis france, france - zolpidēma tartrāts - apvalkotā tablete - 10 mg
imovane 7,5 mg apvalkotās tabletes
sanofi - aventis france, france - zopiklons - apvalkotā tablete - 7,5 mg
lokren 20 mg apvalkotās tabletes
sanofi-aventis france, france - betaksolola hidrohlorīds - apvalkotās tabletes - 20 mg
stilnox 10 mg apvalkotās tabletes
sanofi-aventis france, france - zolpidēma tartrāts - apvalkotā tablete - 10 mg
stilnox 10 mg apvalkotās tabletes
sanofi-aventis france, france - zolpidēma tartrāts - apvalkotā tablete - 10 mg
stilnox 10 mg apvalkotās tabletes
sanofi romania s.r.l., romania - zolpidēma tartrāts - apvalkotā tablete - 10 mg
stilnox 10 mg apvalkotās tabletes
sanofi romania s.r.l., romania - zolpidēma tartrāts - apvalkotā tablete - 10 mg